QMPSF is sensitive and specific in the detection of NPHP1 heterozygous deletions

Eszter Jávorszky 1 , 2 , Vincent Morinière 3 , Andrea Kerti 2 , Eszter Balogh 1 , 2 , Henriett Pikó 4 , Sophie Saunier 5 , 6 , Veronika Karcagi 4 , Corinne Antignac 3 , 5 , 6 ,  and Kálmán Tory 1 , 2
  • 1 MTA-SE Lendulet Nephrogenetic Laboratory, Budapest, Hungary
  • 2 1st Department of Pediatrics, Semmelweis University, Budapest, Hungary
  • 3 Assistance Publique-Hôpitaux de Paris, Department of Genetics, Necker Hospital, Paris, France
  • 4 National Institute of Environmental Health, Department of Molecular Genetics and Diagnostics, Budapest, Hungary
  • 5 Inserm UMR 1163, Laboratory of Hereditary Kidney Diseases, Paris, France
  • 6 Paris Descartes University – Sorbonne Paris Cité, Imagine Institute, Paris, France
Eszter Jávorszky, Vincent Morinière, Andrea Kerti, Eszter Balogh, Henriett Pikó, Sophie Saunier, Veronika Karcagi, Corinne Antignac and Kálmán Tory

Abstract

Background:

Nephronophthisis, an autosomal recessive nephropathy, is responsible for 10% of childhood chronic renal failure. The deletion of its major gene, NPHP1, with a minor allele frequency of 0.24% in the general population, is the most common mutation leading to a monogenic form of childhood chronic renal failure. It is challenging to detect it in the heterozygous state. We aimed to evaluate the sensitivity and the specificity of the quantitative multiplex PCR of short fluorescent fragments (QMPSF) in its detection.

Methods:

After setting up the protocol of QMPSF, we validated it on 39 individuals diagnosed by multiplex ligation-dependent probe amplification (MLPA) with normal NPHP1 copy number (n=17), with heterozygous deletion (n=13, seven parents and six patients), or with homozygous deletion (n=9). To assess the rate of the deletions that arise from independent events, deleted alleles were haplotyped.

Results:

The results of QMPSF and MLPA correlated perfectly in the identification of 76 heterozygously deleted and 56 homozygously deleted exons. The inter-experimental variability of the dosage quotient obtained by QMPSF was low: control, 1.05 (median; range, 0.86−1.33, n = 102 exons); heterozygous deletion, 0.51 (0.42−0.67, n = 76 exons); homozygous deletion, 0 (0−0, n = 56 exons). All patients harboring a heterozygous deletion were found to carry a hemizygous mutation. At least 15 out of 18 deletions appeared on different haplotypes and one deletion appeared de novo.

Conclusions:

The cost- and time-effective QMPSF has a 100% sensitivity and specificity in the detection of NPHP1 deletion. The potential de novo appearance of NPHP1 deletions makes its segregation analysis highly recommended in clinical practice.

  • 1.

    Salomon R, Saunier S, Niaudet P. Nephronophthisis. Pediatr Nephrol 2009;24:2333–44.

    • Crossref
    • PubMed
    • Export Citation
  • 2.

    Halbritter J, Porath JD, Diaz KA, Braun DA, Kohl S, Chaki M, et al. Identification of 99 novel mutations in a worldwide cohort of 1,056 patients with a nephronophthisis-related ciliopathy. Hum Genet 2013;132:865–84.

    • Crossref
    • Export Citation
  • 3.

    Saunier S, Calado J, Heilig R, Silbermann F, Benessy F, Morin G, et al. A novel gene that encodes a protein with a putative src homology 3 domain is a candidate gene for familial juvenile nephronophthisis. Hum Mol Genet 1997;6:2317–23.

    • Crossref
    • PubMed
    • Export Citation
  • 4.

    Saunier S, Calado J, Benessy F, Silbermann F, Heilig R, Weissenbach J, et al. Characterization of the NPHP1 locus: mutational mechanism involved in deletions in familial juvenile nephronophthisis. Am J Hum Genet 2000;66:778–89.

    • Crossref
    • PubMed
    • Export Citation
  • 5.

    Coe BP, Witherspoon K, Rosenfeld JA, van Bon BW, Vulto-van Silfhout AT, Bosco P, et al. Refining analyses of copy number variation identifies specific genes associated with developmental delay. Nat Genet 2014;46:1063–71.

    • Crossref
    • PubMed
    • Export Citation
  • 6.

    Konrad M, Saunier S, Heidet L, Silbermann F, Benessy F, Calado J, et al. Large homozygous deletions of the 2q13 region are a major cause of juvenile nephronophthisis. Hum Mol Genet 1996;5:367–71.

    • Crossref
    • PubMed
    • Export Citation
  • 7.

    Haghighi A, Savaj S, Haghighi-Kakhki H, Benoit V, Grisart B, Dahan K. Identification of an NPHP1 deletion causing adult form of nephronophthisis. Ir J Med Sci 2016;185:589–95.

    • Crossref
    • PubMed
    • Export Citation
  • 8.

    Lindstrand A, Davis EE, Carvalho CM, Pehlivan D, Willer JR, Tsai IC, et al. Recurrent CNVs and SNVs at the NPHP1 locus contribute pathogenic alleles to Bardet-Biedl syndrome. Am J Hum Genet 2014;94:745–54.

    • Crossref
    • PubMed
    • Export Citation
  • 9.

    Hildebrandt F, Rensing C, Betz R, Sommer U, Birnbaum S, Imm A, et al. Establishing an algorithm for molecular genetic diagnostics in 127 families with juvenile nephronophthisis. Kidney Int 2001;59:434–45.

    • Crossref
    • PubMed
    • Export Citation
  • 10.

    Castellsague E, Gonzalez S, Nadal M, Campos O, Guino E, Urioste M, et al. Detection of APC gene deletions using quantitative multiplex PCR of short fluorescent fragments. Clin Chem 2008;54:1132–40.

    • Crossref
    • PubMed
    • Export Citation
  • 11.

    Houdayer C, Gauthier-Villars M, Lauge A, Pages-Berhouet S, Dehainault C, Caux-Moncoutier V, et al. Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSF. Hum Mutat 2004;23:193–202.

    • Crossref
    • PubMed
    • Export Citation
  • 12.

    Mo ZP, Yu CS, Li YJ, Cao WX, Zeng ZY, Zhan YX, et al. Detection of alpha-globin gene deletion and duplication using quantitative multiplex PCR of short fluorescent fragments. Clin Chem Lab Med 2012;50:649–54.

  • 13.

    Rouzier C, Chaussenot A, Serre V, Fragaki K, Bannwarth S, Ait-El-Mkadem S, et al. Quantitative multiplex PCR of short fluorescent fragments for the detection of large intragenic POLG rearrangements in a large French cohort. Eur J Hum Genet 2014;22:542–50.

    • Crossref
    • Export Citation
  • 14.

    Saugier-Veber P, Goldenberg A, Drouin-Garraud V, de La Rochebrochard C, Layet V, Drouot N, et al. Simple detection of genomic microdeletions and microduplications using QMPSF in patients with idiopathic mental retardation. Eur J Hum Genet 2006;14:1009–17.

    • Crossref
    • PubMed
    • Export Citation
  • 15.

    Vaurs-Barriere C, Bonnet-Dupeyron MN, Combes P, Gauthier-Barichard F, Reveles XT, Schiffmann R, et al. Golli-MBP copy number analysis by FISH, QMPSF and MAPH in 195 patients with hypomyelinating leukodystrophies. Ann Hum Genet 2006;70(Pt 1):66–77.

    • Crossref
    • PubMed
    • Export Citation
  • 16.

    Bellanne-Chantelot C, Clauin S, Chauveau D, Collin P, Daumont M, Douillard C, et al. Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes 2005;54:3126–32.

    • Crossref
    • PubMed
    • Export Citation
  • 17.

    Jardin F, Ruminy P, Kerckaert JP, Parmentier F, Picquenot JM, Quief S, et al. Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas. Haematologica 2008;93:543–50.

    • Crossref
    • PubMed
    • Export Citation
  • 18.

    Ferreira MC, Dorboz I, Rodriguez D, Boespflug TO. Screening for GFAP rearrangements in a cohort of Alexander disease and undetermined leukoencephalopathy patients. Eur J Med Genet 2015;58:466–70.

    • Crossref
    • Export Citation
  • 19.

    Tory K, Lacoste T, Burglen L, Moriniere V, Boddaert N, Macher MA, et al. High NPHP1 and NPHP6 mutation rate in patients with Joubert syndrome and nephronophthisis: potential epistatic effect of NPHP6 and AHI1 mutations in patients with NPHP1 mutations. J Am Soc Nephrol 2007;18:1566–75.

    • Crossref
    • PubMed
    • Export Citation
  • 20.

    Nicolas G, Rovelet-Lecrux A, Pottier C, Martinaud O, Wallon D, Vernier L, et al. PDGFB partial deletion: a new, rare mechanism causing brain calcification with leukoencephalopathy. J Mol Neurosci 2014;53:171–5.

    • Crossref
    • PubMed
    • Export Citation
  • 21.

    Gouas L, Goumy C, Veronese L, Tchirkov A, Vago P. Gene dosage methods as diagnostic tools for the identification of chromosome abnormalities. Pathol Biol (Paris) 2008;56:345–53.

    • Crossref
    • PubMed
    • Export Citation
  • 22.

    Hyon C, Mansour-Hendili L, Chantot-Bastaraud S, Donadille B, Kerlan V, Dode C, et al. Deletion of CPEB1 gene: a rare but recurrent cause of premature ovarian insufficiency (POI). J Clin Endocrinol Metab 2016;101:2099–104.

    • Crossref
    • PubMed
    • Export Citation
  • 23.

    Kiehntopf M, Varga RE, Koch HG, Beetz C. A homemade MLPA assay detects known CTNS mutations and identifies a novel deletion in a previously unresolved cystinosis family. Gene 2012;495:89–92.

    • Crossref
    • Export Citation
  • 24.

    Zhang X, Xu Y, Liu D, Geng J, Chen S, Jiang Z, et al. A modified multiplex ligation-dependent probe amplification method for the detection of 22q11.2 copy number variations in patients with congenital heart disease. BMC Genomics 2015;16:364.

    • Crossref
    • PubMed
    • Export Citation
  • 25.

    Nothwang HG, Stubanus M, Adolphs J, Hanusch H, Vossmerbaumer U, Denich D, et al. Construction of a gene map of the nephronophthisis type 1 (NPHP1) region on human chromosome 2q12-q13. Genomics 1998;47:276–85.

    • Crossref
    • PubMed
    • Export Citation
  • 26.

    Hildebrandt F, Singh-Sawhney I, Schnieders B, Papenfuss T, Brandis M. Refined genetic mapping of a gene for familial juvenile nephronophthisis (NPH1) and physical mapping of linked markers. APN Study Group. Genomics 1995;25:360–4.

    • Crossref
    • Export Citation
  • 27.

    Scolari F, Ghiggeri GM, Casari G, Amoroso A, Puzzer D, Caridi GL, et al. Autosomal dominant medullary cystic disease: a disorder with variable clinical pictures and exclusion of linkage with the NPH1 locus. Nephrol Dial Transplant 1998;13:2536–46.

    • Crossref
    • PubMed
    • Export Citation
  • 28.

    Konrad M, Saunier S, Calado J, Gubler MC, Broyer M, Antignac C. Familial juvenile nephronophthisis. J Mol Med (Berl) 1998;76:310–6.

    • Crossref
    • PubMed
    • Export Citation
  • 29.

    Exome Variant Server NGESPE. Seattle, WA (URL: http://evs.gs.washington.edu/EVS/).

  • 30.

    Chaari I, Trabelsi M, Goucha R, Elaribi Y, Kharrat M, Guarguah T, et al. Prevalence and incidence estimation of large NPHP1 homozygous deletion in Tunisian population. Pathol Biol (Paris) 2012;60:e84–6.

    • Crossref
    • PubMed
    • Export Citation
  • 31.

    Caridi G, Dagnino M, Gusmano R, Ginevri F, Murer L, Ghio L, et al. Clinical and molecular heterogeneity of juvenile nephronophthisis in Italy: insights from molecular screening. Am J Kidney Dis 2000;35:44–51.

    • Crossref
    • PubMed
    • Export Citation
  • 32.

    Hildebrandt F, Otto E, Rensing C, Nothwang HG, Vollmer M, Adolphs J, et al. A novel gene encoding an SH3 domain protein is mutated in nephronophthisis type 1. Nat Genet 1997;17:149–53.

    • Crossref
    • PubMed
    • Export Citation
  • 33.

    Campbell IM, Yuan B, Robberecht C, Pfundt R, Szafranski P, McEntagart ME, et al. Parental somatic mosaicism is underrecognized and influences recurrence risk of genomic disorders. Am J Hum Genet 2014;95:173–82.

    • Crossref
    • PubMed
    • Export Citation
  • 34.

    Dittwald P, Gambin T, Szafranski P, Li J, Amato S, Divon MY, et al. NAHR-mediated copy-number variants in a clinical population: mechanistic insights into both genomic disorders and Mendelizing traits. Genome Res 2013;23:1395–409.

    • Crossref
    • Export Citation
  • 35.

    Parisi MA, Bennett CL, Eckert ML, Dobyns WB, Gleeson JG, Shaw DW, et al. The NPHP1 gene deletion associated with juvenile nephronophthisis is present in a subset of individuals with Joubert syndrome. Am J Hum Genet 2004;75:82–91.

    • Crossref
    • Export Citation
  • 36.

    Roberts JL, Hovanes K, Dasouki M, Manzardo AM, Butler MG. Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services. Gene 2014;535:70–8.

    • Crossref
    • PubMed
    • Export Citation
Purchase article
Get instant unlimited access to the article.
$42.00
Log in
Already have access? Please log in.


or
Log in with your institution

Journal + Issues

Clinical Chemistry and Laboratory Medicine ( CCLM) publishes articles on novel teaching and training methods applicable to laboratory medicine. CCLM welcomes contributions on the progress in fundamental and applied research and cutting-edge clinical laboratory medicine. It is one of the leading journals in the field, with an impact factor of over three. CCLM is the official journal of nine national clinical societies and associated with EFLM.

Search